Log In
Friday 22nd June 2018

Cyber patient joins fight

12th October 2006

Cyber patients could soon be used to test out the success of treatment before it is given to real patients, according to a new study. A computer-generated virtual cancer patient has already been found to be able to predict how patients with advanced breast cancer will respond to treatment with 70 per cent accuracy, in a study of 33 patients.

The researchers from Nottingham City Hospital and the Institute for Medical Biomathematics in Israel carried out a retrospective study of the patients with advanced breast cancer that had spread to the liver, lymph nodes and lungs.

Revealed at a specialist cancer conference in Birmingham, the Cancer Research UK-funded study used the Optimata virtual cancer patient to predict response to two chemotherapy drugs: docetaxel and doxorubicin. The trial could eventually help specialists decide which treatments to offer individual patients and improve their survival rate.


Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Mayden - Innovative cloud-based web development for the healthcare sector
© Mayden Foundation 2018